Biosynthesis of NO: Mechanism, regulation and control;Biosynthese du monoxyde d'azote (NO): mecanisme, regulation et controle

Medecine/Sciences

Volumn 14, Issue 11, 1998, Pages 1185-1195

  Sennequier, Nicolas ^a   Vadon Le Goff, Sandrine ^b  

^a PSL RESEARCH UNIVERSITY   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CITRULLINE; CYTOCHROME P450 REDUCTASE; HEME; ISOENZYME; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXYGEN; PEROXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TETRAHYDROBIOPTERIN; VASODILATOR AGENT;

ARTICLE; BLOOD PRESSURE REGULATION; ENZYME REGULATION; ENZYME STRUCTURE; OXIDATION; SEQUENCE HOMOLOGY;

EID: 0031742832     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.4267/10608/936     Document Type: Article

References (48)

1. Kerwin JF, Lancaster JR, Feldman PL. Nitric oxide : a new paradigm for second messengers. J Med Chem 1995; 38: 4343-62.
2. Lancaster JR. Simulation of the diffusion and reaction of endogenously produced nitric oxide. Proc Natl Acad Sci USA 1994; 91: 8137-41.
3. Packer L. Methods in enzymology. London: Academic Press, 1996: 58-259.
4. Stuehr DJ. Structure-function aspects in the nitric oxide synthases. Ann Rev Pharmacol Toxicol 1997; 37: 339-59.
5. Brenman JE, Chao DS, Xia H, Aldape K, Bredt DS. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 1995; 82: 743-52.
6. Forstermann U, Gath I, Schwarz P, Closs EI, Kleinert H. Isoforms of nitric oxide synthase. Properties, cellular distribution and expressional control. Biochem Pharmacol 1995; 50: 1321-32.
7. Michel T, Feron O. Nitric oxide synthases : which, where, how, and why? J Clin Invest 1997; 100: 2146-52.
8. Stuehr DJ, Ikeda-Saito M. Spectral characterization of brain and macrophage nitric-oxide synthases - cytochrome-P-450-like hemeproteins that contain a flavin semiquinone radical. J Biol Chem 1992; 267: 20547-50.
9. Renaud JP, Boucher JL, Vadon S, Delaforge M, Mansuy D. Particular ability of liver P450s3A to catalyze the oxidation of Nω-hydroxyarginine to citrulline and nitrogen oxides and occurence in NO synthases of a sequence very similar to the heme-binding sequence in P450s. Biochem Biophys Res Commun 1993; 192: 53-60.
10. Ghosh DK, Abu-Soud HM, Stuehr DJ. Domains of macrophage NO synthase have divergent roles in forming and stabilizing the active dimeric enzyme. Biochemistry 1996; 35: 1444-9.
11. Venema RC, Ju H, Zou R, Ryan JW, Venema VJ. Subunit interactions of endothelial nitric-oxide synthase. Comparisons to the neuronal and inducible nitric-oxide synthase isoforms. J Biol Chem 1997; 272: 1276-82.
12. Hellermann GR, Solomonson LP. Calmodulin promotes dimerization of the oxygenase domain of human endothelial nitric-oxide synthase. J Biol Chem 1997; 272: 12030-4.
13. Presta A, Siddhanta U, Wu C, et al. Comparative functioning of dihydro- and tetrahydrobiopterins in supporting electron transfer, catalysis and subunit dimerization in inducible NO synthase. Biochemistry 1998; 37: 298-310.
14. Sennequier N, Stuehr DJ. Analysis of substrate-induced electronic, catalytic, and structural changes in inducible NO synthase. Biochemistry 1996; 35: 5883-92.
15. Venema RC, Sayegh HS, Kent JD, Harrison DG. Identification, characterization, and comparison of the calmodulin-binding domains of the endothelial and inducible nitric oxide synthases. J Biol Chem 1996; 271: 6435-40.
16. Klatt P, Pfeiffer S, List BM, et al. Characterization of heme-deficient neuronal nitricoxide synthase reveals a role for heme in subunit dimerization and binding of the amino acid substrate and tetrahydrobiopterin. J Biol Chem 1996; 271: 7336-42.
17. Gorren AC, List BM, Schrammel A, et al. Tetrahydrobiopterin-free neuronal nitric oxide synthase: evidence for two identical highly anticooperative pteridine binding sites. Biochemistry 1996; 35: 16735-45.
18. Crane BR, Arvai AS, Gachhui R, et al. The structure of nitric oxide synthase oxygenase domain and inhibitor complexes. Sciene 1997; 278: 425-31.
19. Crane BR, Arvai AS, Ghosh DK, et al. Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. Science 1998; 279: 2121-6.
20. Ortiz de Montellano PR. Cytochrome P450: structure, mechanism, and biochemistry. New York: Plenum Press, 1995: 556.
21. Abu-Soud HM, Presta A, Mayer B, Stuehr DJ. Analysis of neuronal NO synthase under single-turnover conditions: conversion of Nω-hydroxyarginine to nitric oxide and citrulline. Biochemistry 1997; 36: 10811-6.
22. 2 to nitric oxide and citrulline. Biochem Biophys Res Commun 1992; 187: 880-6.
23. Sennequier N, Boucher JL, Battioni P, Mansuy D. Superoxide anion efficiently performs the oxidative cleavage of C = NOH bonds of amidoximes and N-hydroxyguanidines with formation of nitrogen oxides. Tetrahedron Lett 1995; 36: 6059-62.
24. Mansuy D, Boucher JL, Clement B. On the mechanism of nitric oxide formation upon oxidative cleavage of C = N (OH) bonds by NO-synthases and cytochromes P450. Biochimie 1995; 77: 661-7.
25. Thiemermann C. Inhibition des synthases de monoxyde d'azote dans la défaillance circulatoire: effet bénéfique ou délétère Med Sci 1995; 11: 1643-51.
26. Abu-Soud HM, Yoho LL, Stuehr DJ. Calmodulin controls neuronal nitric-oxide synthase by a dual mechanism - activation of intra- and interdomain electron transfer. J Biol Chem 1994; 269: 32047-50.
27. Jaffrey SR, Snyder SH. PIN: an associated protein inhibitor of neuronal nitric oxide synthase. Science 1996; 274: 774-7.
28. Chang CI, Liao JC, Kuo L. Arginase modulates nitric oxide production in activated macrophages. Am J Physiol 1998; 43: H342-8.
29. Boucher JL, Custot J, Vadon S, et al. N-omega-hydroxy-L-arginine, an intermediate in the L-arginine to nitric oxide pathway, is a strong inhibitor of liver and macrophage arginase. Biochem Biophys Res Commun 1994; 203: 1614-21.
30. Dweik RA, Laskowski D, Abu-Soud HM, et al. Nitric oxide synthesis in the lung. Regulation by oxygen through a kinetic mechanism. J Clin Invest 1998; 101: 660-6.
31. Harrison DG. Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 1997; 100: 2153-7.
32. Nathan C. Inducible nitric oxide synthase: what difference does it make? J Clin Invest 1997; 100: 2417-23.
33. Christopherson KS, Bredt DS. Nitric oxide in excitable tissues: Physiological roles and disease. J Clin Invest 1997; 100: 2424-9.
34. Kendrick KM, Guevara-Guzman R, Zorrilla J, et al. Formation of olfactory memories mediated by nitric oxide. Nature 1997; 388: 670-4.
35. Smalt R, Mitchell FT, Howard RL, Chambers TJ. Induction of NO and prostaglandin E-2 in osteoblasts by wall-shear stress but not mechanical strain. Am J Physiol 1997; 36: E751-8.
36. Endo S, Inada K, Nakae H, et al. Nitrite/nitrate oxide (NOx) and cytokine levels in patients with septic shock. Res Commun Mol Pathol Pharmacol 1996; 91: 347-56.
37. Mac Micking JD, Nathan C, Hom G, et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995; 81: 641-50.
38. Ou J, Carlos TM, Watkins SC, et al. Differential effects of nonselective nitric oxide synthase (NOS) and selective inducible NOS inhibition on hepatic necrosis, apoptosis, ICAM-1 expression, and neutrophil accumulation during endotoxemia. Nitric Oxide Biol Chem 1997; 1: 404-16.
39. Rosselet A, Feihl F, Markert M, et al. Selective iNOS inhibition is superior to norepinephrine in the treatment of rat endotoxic shock. Am J Respir Crit Care Med 1998; 157: 162-70.
40. Liaudet L, Rosselet A, Schaller MD, et al. Nonselective versus selective inhibition of inducible nitric oxide synthase in experimental endotoxic shock. J Infect Dis 1998; 177: 127-32.
41. Fukuto JM, Chaudhuri G. Inhibition of constitutive and inducible nitric oxide synthase: potential selective inhibition. Annu Rev Pharmacol Toxicol 1995; 35: 165-94.
42. Su Z, Blazing MA, Fan D, George SE. The calmodulin-nitric oxide synthase interaction. Critical role of the calmodulin latch domain in enzyme activation. J Biol Chem 1995; 270: 29117-22.
43. Wolff DJ, Gribin BJ. The inhibition of the constitutive and inducible nitric oxide synthase isoforms by indazole agents. Arch Biochem Biophys 1994; 311: 300-6.
44. Vadon-Le Goff S, Tenu JP. Nitric oxide biosynthesis in mammals. In: Henry YA, Guissani A, Ducastel B, eds. Nitric oxide from chemistry to biology: EPR spectroscopy of nytrosylated compounds. Paris: Landes, 1996: 173-90.
45. Wolff DJ, Lubeskie A. Aminoguanidine is an isolorm-selective, mechanism-based inactivator of nitric oxide synthase. Arch Biochem Biophys 1995; 316: 290-301.
46. Garvey EP, Oplinger JA, Tanoury GJ, et al. Potent and selective inhibition of human nitric oxide synthases. Inhibition by non-amino acid isothioureas. J Biol Chem 1994; 269: 26669-76.
47. Garvey EP, Oplinger JA, Furfine ES, et al. 1400W is a slow, tight binding and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem 1997; 272: 4959-63.
48. Zhang HQ, Fast W, Marletta MA, Martasek P, Silverman RB. Potent and selective inhibition of neuronal nitric oxide synthase by Nω-propyl-L-arginine. J Med Chem 1997; 40: 3869-70.